Ross Eye Institute
Buffalo, New York, 14209, United States
Location status: Recruiting
NCT Number: NCT05523622
We are testing the accuracy of Reichert's Tono-Vera tonometer by comparing measurements of IOP with this device and measurements with other commonly-used tonometers, including Goldmann Applanation and iCare.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
Buffalo, New York, 14209, United States
Location status: Recruiting
This is a comparative study between the TonoVera, the gold standard Goldmann Applanation Tonometry (GAT) and an established rebound tonometry device, iCare. IOP measurements will be obtained using the following devices: Reichert's prototype Tono-Vera Rebound tonometer (a rebound tonometer in development), iCare's iC100 rebound tonometer (a device commonly used in clinical practice), GAT (a device commonly used in clinical practice). Reichert's iPac Handheld Pachymeter (a device commonly used in clinical practice) will be used to measure the test subject's Central Corneal Thickness (CCT), measured in µm if CCT is not already on file. An Autorefractor Keratometer (ARK) (a device commonly used in clinical practice) will be used to measure necessary vision correction and corneal curvature. The Ocular Response Analyzer (a device commonly used in clinical practice) will be used to measure corneal hysteresis. Multiple IOP measurements will be taken with each device on each eye for all subjects: 3 along the central cornea, 3 along the peripheral cornea, and 3 along the sclera.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Male or female patients aged 18 to 99 Patients in good general health as evidenced by ability to come to their appointment on day of study.
Exclusion criteria
The tonometer measures intraocular pressure with a small rebound probe, similar to those used with other tonometers currently on the market, such as the iCare.
This is the current gold standard for measuring eye pressure.
Time frame: Baseline only
pressure inside the eye
Contact information is provided by the study sponsor or research team.
Catherine Seeger, MD
CONTACT
Sandra Sieminski, MD
CONTACT
State University of New York at Buffalo
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07036510
Cataract, Eye Diseases
Panama City, Panama
View Trial DetailsNCT05924477
Eye Diseases, Glaucoma
San Francisco, California, United States
View Trial DetailsNCT07425535
Eye Diseases, Glaucoma
Baltimore, Maryland, United States
View Trial DetailsNCT07341763
Behavior, Cone-Rod Dystrophies
Waterloo, Ontario, Canada
View Trial Details